Onkos Surgical, Inc.

Onkos Surgical, Inc. is a US-based company specializing in innovative surgical solutions for oncology, focusing on enhancing patient outcomes through advanced technology and product offerings. Founded in 2015 in Parsippany-Troy Hills, US, Onkos Surgical, Inc. develops surgical solutions aimed at improving oncology care.

The company was co-founded by Antony Koblish and Patrick Treacy, who have extensive backgrounds in medical technology. Onkos Surgical has closed 6 funding deals, with the latest being a Series C round amounting to USD 15. 00 mn led by 1315 Capital as of January 2025, marking the total funds raised at USD 15. 00 mn.

Onkos Surgical, Inc. specializes in surgical solutions designed for oncology, including innovative products that enhance surgical precision and outcomes. Their offerings aim to address challenges in surgical oncology by providing tools that improve surgical workflows and patient care. The company markets its products primarily in North America and Europe, targeting healthcare providers and institutions.

The company generates revenue through a subscription-based model, allowing healthcare providers to access their suite of surgical products and services for a recurring fee. This model ensures predictable revenue streams through annual and monthly contracts, facilitating both direct sales and B2B partnerships with healthcare institutions. Onkos Surgical, Inc. plans to utilize the recent funding of USD 35 million raised in January 2025 for the development and launch of its innovative product, NanoCept.

The company is also looking to expand its market presence internationally, specifically targeting healthcare systems in Europe and Asia by 2026, in line with its strategic growth initiatives.